COVID-19 antibodies ‘last at least six months’ in most people
Study shows that six months after infection, up to 88% of people still have antibodies in their blood
A study of almost 1,700 people suggests that, six months after infection, up to 88% of people still have antibodies in their blood that can fight against COVID-19.
The data comes from one of the world s largest studies to follow up with COVID-19 patients and also provided more details about the symptoms that those who had the virus are likely to have experienced.
A high number (43%) reported losing their sense of taste or smell, while others reported having a cough (26%) or a fever (28%). Equally of interest was that 40% of participants experienced none of these symptoms, and about 20% had no symptoms at all.
Coronavirus updates LIVE: Matt Hancock promises strong border action in fight against variants
chroniclelive.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chroniclelive.co.uk Daily Mail and Mail on Sunday newspapers.
5 things you need to know now - Officer Brian Sicknick lies in honor at Capitol Rotunda
theweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theweek.com Daily Mail and Mail on Sunday newspapers.
| UPDATED: 10:36, Wed, Feb 3, 2021
Link copied Sign up for our columnists plus the most commented stories driving conversation
SUBSCRIBE Invalid email
When you subscribe we will use the information you provide to send you these newsletters.
Sometimes they ll include recommendations for other related newsletters or services we offer.
Our Privacy Notice explains more about how we use your data, and your rights.
You can unsubscribe at any time.
It also suggested that around 8.8 per cent of the population had been infected by December. London was highest (12.4 per cent) and Scotland lowest (5.5 per cent).
Professor Naomi Allen, chief scientist at the UK Biobank, said: The results suggest that people may be protected against subsequent infection for at least six months following natural infection.